---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042685"
form_type: "8-K"
ticker: "CETX"
cik: "0001435064"
company_name: "CEMTREX INC"
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:38:11.259264+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Cemtrex gets Nasdaq extension to Feb 17, 2025 to cure equity deficiency

## Summary
- Nasdaq granted extension for minimum $2.5M stockholders' equity compliance.
- Company must complete financing by Feb 17, 2025 and evidence compliance.
- Plans include exercising ~$10M in warrant liabilities and converting ~$12M debt to equity.
- Projected equity of $10M by Dec 31, 2024 per company submission.
- Failure to evidence compliance by March 31, 2025 periodic filing may lead to delisting.

## SEC filing metadata
- accession: 0001493152-24-042685
- form_type: 8-K
- ticker: CETX
- cik: 0001435064
- company_name: CEMTREX INC
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1435064/000149315224042685/0001493152-24-042685-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1435064/000149315224042685/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042685
- JSON: https://secwatch.observer/filing/0001493152-24-042685.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042685.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.